Oncotarget: Improved therapeutic efficacy of unmodified anti-tumor antibodies
Bioengineer.org,
The Oncotarget findings suggest that MEKi induced an increased expression of tumor-associated antigens, which in combination…
The Oncotarget findings suggest that MEKi induced an increased expression of tumor-associated antigens, which in combination…
The Oncotarget findings suggest that MEKi induced an increased expression of tumor-associated antigens, which in combination…
The cover for issue 2 of Oncotarget features Figure 4, "Combination therapy TA99/ICB reduced the lung tumor burden in the B16…